Abstract
Summary
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
LPI (LP Information)' newest research report, the “Congestive Heart Failure (CHF) Treatment Devices Industry Forecast” looks at past sales and reviews total world Congestive Heart Failure (CHF) Treatment Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Congestive Heart Failure (CHF) Treatment Devices sales for 2023 through 2029. With Congestive Heart Failure (CHF) Treatment Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Congestive Heart Failure (CHF) Treatment Devices industry.
This Insight Report provides a comprehensive analysis of the global Congestive Heart Failure (CHF) Treatment Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Congestive Heart Failure (CHF) Treatment Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Congestive Heart Failure (CHF) Treatment Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Congestive Heart Failure (CHF) Treatment Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Congestive Heart Failure (CHF) Treatment Devices.
The global Congestive Heart Failure (CHF) Treatment Devices market size is projected to grow from US$ 4875.8 million in 2022 to US$ 6085.2 million in 2029; it is expected to grow at a CAGR of 6085.2 from 2023 to 2029.
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
This report presents a comprehensive overview, market shares, and growth opportunities of Congestive Heart Failure (CHF) Treatment Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Segmentation by application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott
Key Questions Addressed in this Report
What is the 10-year outlook for the global Congestive Heart Failure (CHF) Treatment Devices market?
What factors are driving Congestive Heart Failure (CHF) Treatment Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Congestive Heart Failure (CHF) Treatment Devices market opportunities vary by end market size?
How does Congestive Heart Failure (CHF) Treatment Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Congestive Heart Failure (CHF) Treatment Devices Industry Forecast” looks at past sales and reviews total world Congestive Heart Failure (CHF) Treatment Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Congestive Heart Failure (CHF) Treatment Devices sales for 2023 through 2029. With Congestive Heart Failure (CHF) Treatment Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Congestive Heart Failure (CHF) Treatment Devices industry.
This Insight Report provides a comprehensive analysis of the global Congestive Heart Failure (CHF) Treatment Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Congestive Heart Failure (CHF) Treatment Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Congestive Heart Failure (CHF) Treatment Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Congestive Heart Failure (CHF) Treatment Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Congestive Heart Failure (CHF) Treatment Devices.
The global Congestive Heart Failure (CHF) Treatment Devices market size is projected to grow from US$ 4875.8 million in 2022 to US$ 6085.2 million in 2029; it is expected to grow at a CAGR of 6085.2 from 2023 to 2029.
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
This report presents a comprehensive overview, market shares, and growth opportunities of Congestive Heart Failure (CHF) Treatment Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Segmentation by application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott
Key Questions Addressed in this Report
What is the 10-year outlook for the global Congestive Heart Failure (CHF) Treatment Devices market?
What factors are driving Congestive Heart Failure (CHF) Treatment Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Congestive Heart Failure (CHF) Treatment Devices market opportunities vary by end market size?
How does Congestive Heart Failure (CHF) Treatment Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Country/Region, 2018, 2022 & 2029
2.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
2.2.1 Cardiac Resynchronization Therapy (CRT)
2.2.2 Implantable Cardioverter Defibrillators (ICDs)
2.3 Congestive Heart Failure (CHF) Treatment Devices Sales by Type
2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type (2018-2023)
2.4 Congestive Heart Failure (CHF) Treatment Devices Segment by Application
2.4.1 Left Ventricular Assist Device (LVAD)
2.4.2 Right Ventricular Assist Device (RVAD)
2.4.3 Biventricular Assist Device (BIVAD)
2.5 Congestive Heart Failure (CHF) Treatment Devices Sales by Application
2.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application (2018-2023)
3 Global Congestive Heart Failure (CHF) Treatment Devices by Company
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Breakdown Data by Company
3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales by Company (2018-2023)
3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2018-2023)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2018-2023)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2018-2023)
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Company
3.4 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Location Distribution
3.4.2 Players Congestive Heart Failure (CHF) Treatment Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region
4.1 World Historic Congestive Heart Failure (CHF) Treatment Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Congestive Heart Failure (CHF) Treatment Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Congestive Heart Failure (CHF) Treatment Devices Sales Growth
4.4 APAC Congestive Heart Failure (CHF) Treatment Devices Sales Growth
4.5 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Growth
4.6 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Growth
5 Americas
5.1 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Country
5.1.1 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023)
5.1.2 Americas Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023)
5.2 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Type
5.3 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Region
6.1.1 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023)
6.1.2 APAC Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2023)
6.2 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Type
6.3 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Congestive Heart Failure (CHF) Treatment Devices by Country
7.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023)
7.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023)
7.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type
7.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices by Country
8.1.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type
8.3 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Congestive Heart Failure (CHF) Treatment Devices
10.3 Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices
10.4 Industry Chain Structure of Congestive Heart Failure (CHF) Treatment Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
11.3 Congestive Heart Failure (CHF) Treatment Devices Customer
12 World Forecast Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region
12.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Region
12.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Region (2024-2029)
12.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Type
12.7 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Application
13 Key Players Analysis
13.1 Abiomed
13.1.1 Abiomed Company Information
13.1.2 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abiomed Main Business Overview
13.1.5 Abiomed Latest Developments
13.2 Berlin Heart GmbH
13.2.1 Berlin Heart GmbH Company Information
13.2.2 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Berlin Heart GmbH Main Business Overview
13.2.5 Berlin Heart GmbH Latest Developments
13.3 Biotronik SE & Co. KG
13.3.1 Biotronik SE & Co. KG Company Information
13.3.2 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotronik SE & Co. KG Main Business Overview
13.3.5 Biotronik SE & Co. KG Latest Developments
13.4 Boston Scientific Corporation
13.4.1 Boston Scientific Corporation Company Information
13.4.2 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Corporation Main Business Overview
13.4.5 Boston Scientific Corporation Latest Developments
13.5 HeartWare International
13.5.1 HeartWare International Company Information
13.5.2 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HeartWare International Main Business Overview
13.5.5 HeartWare International Latest Developments
13.6 Jarvik Heart
13.6.1 Jarvik Heart Company Information
13.6.2 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jarvik Heart Main Business Overview
13.6.5 Jarvik Heart Latest Developments
13.7 LivaNova PLC
13.7.1 LivaNova PLC Company Information
13.7.2 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LivaNova PLC Main Business Overview
13.7.5 LivaNova PLC Latest Developments
13.8 Medtronic
13.8.1 Medtronic Company Information
13.8.2 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medtronic Main Business Overview
13.8.5 Medtronic Latest Developments
13.9 ReliantHeart
13.9.1 ReliantHeart Company Information
13.9.2 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ReliantHeart Main Business Overview
13.9.5 ReliantHeart Latest Developments
13.10 Abbott
13.10.1 Abbott Company Information
13.10.2 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Abbott Main Business Overview
13.10.5 Abbott Latest Developments
14 Research Findings and Conclusion